Report

As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.

Expert Market Research Thumbnail Image

Global Scleroderma Therapeutics Market: By Drug Class: Immunosuppressors, Phosphodiesterase 5 Inhibitors - PHA , Endothelin Receptor Antagonists, Prostacyclin Analogues, Calcium Channel Blockers, Analgesics, Others; By Indication: Systemic, Localized; By Region: North America, Europe, Asia Pacific, Latin America, Middle East & Africa; Historical Production and Consumption (2015-2019); Production and Consumption Forecast (2020-2025); SWOT Analysis; Value Chain Analysis; Competitive Landscape & Supplier Analysis; Events and Developments

Global Scleroderma Therapeutics Market Key Insights:

 

  • Market Overview
  • Market Opportunities
  • Regional Market Analysis
  • Historical Market Size 2015-2019
  • Competitive Landscape
  • SWOT Analysis
  • Market Forecast 2020-2025
  • Events and Developments
  • Market Indicators


Market Outlook

The global scleroderma therapeutics market attained a value of USD 1.7 billion in 2019. The scleroderma therapeutics market is further expected to grow in the forecast period of 2020-2025 at a CAGR of 6.2% to reach USD 2.4 billion by 2025.

Global Scleroderma Therapeutics Market Report and Forecast 2020-2025

Get a Free Sample Report with Table of Content - Download Now

Properties and Applications

Scleroderma refers to an autoimmune condition that affects the skin, vessels of the blood, muscles, and internal organs. Usually, the disease is caused by an abnormal immune response. Immunosuppressive medicines and, in some cases, glucocorticoids are included to treat this condition.
The drug class available in the industry can be divided into:

  • Immunosuppressors
  • Phosphodiesterase 5 Inhibitors - PHA 
  • Endothelin Receptor Antagonists
  • Prostacyclin Analogues
  • Calcium Channel Blockers
  • Analgesics
  • Others

Based on indication, the scleroderma therapeutics market can be divided into:

  • Systemic
  • Localized

The EMR report looks into the regional markets of scleroderma therapeutics like North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific.

Market Analysis

The demand in the industry is mainly being driven by the use of off-label medications approved. The lack of curative drugs and a higher prevalence of off-label drug use are the underlying factors that drive interest in markets for rare diseases. The advancement of targeted biologics, as well as small molecular combination therapies, are expected to be supported in the industry. The market is also projected to be supported by the rising prevalence of scleroderma and the increasing incidences of genetic mutations combined with dramatic changes in the environment. The rising disposable incomes, allowing greater expenditure, and the existence of a well-defined regulatory framework that promotes successful therapy production in developed regions are driving the growth of the industry.

Competitive Landscape

The report presents a detailed analysis of the following key players in the global scleroderma therapeutics market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

  • F. Hoffman La Roche Ltd.
  • Boehringer Ingelheim International GmbH
  • Bristol-Myers Squibb Company [NYSE: BMY]
  • arGentis Pharmaceuticals, Llc
  • Prometic Life Sciences Inc. 
  • Akashi Therapeutics
  • Kadmon Holdings, Inc.
  • Emerald Health Pharmaceuticals. 
  • Others

The EMR report gives an in-depth insight into the scleroderma therapeutics market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.

Key Questions Answered in the Market Report:

  • How has the global scleroderma therapeutics market performed in the previous years (2015-2019)?
  • What is the forecast assessment of the scleroderma therapeutics market for 2020-2025?
  • What are the major drivers of the historical (2015-2019) and forecast (2020-2025) periods?
  • What are the major constraints of the historical (2015-2019) and forecast (2020-2025) periods?
  • What are the major price indicators of the global scleroderma therapeutics market?
  • What are the major demand indicators of the global scleroderma therapeutics market?
  • Who are the key manufacturers in the global scleroderma therapeutics market?
  • What is the degree of competition in the global scleroderma therapeutics market?
  • What are the major events and developments taking place within the global industry?

1    Preface
    1.1    Objectives of the Study
    1.2    Key findings of the Study
2    Research Methodology
    2.1    Data Extraction
    2.2    Data Corroboration
    2.3    Market Structure
    2.4    Inference Data 
3    Executive Summary
    3.1    Market Overview
    3.2    Market Analysis
4    Global Scleroderma Therapeutics Market Analysis
    4.1    Global Scleroderma Therapeutics Historical Market (2015-2019) & Forecast (2020-2025)
    4.2    Global Scleroderma Therapeutics Market Breakup by Drug Class
        4.2.1    Immunosuppressors
        4.2.2    Phosphodiesterase 5 Inhibitors - PHA
        4.2.3    Endothelin Receptor Antagonists
        4.2.4    Prostacyclin Analogues
        4.2.5    Calcium Channel Blockers
        4.2.6    Analgesics
        4.2.7    Others
    4.3    Global Scleroderma Therapeutics Market Breakup by Drug Class: Historical Market (2015-2019) & Forecast (2020-2025)
        4.3.1    Immunosuppressors
        4.3.2    Phosphodiesterase 5 Inhibitors - PHA 
        4.3.3    Endothelin Receptor Antagonists
        4.3.4    Prostacyclin Analogues
        4.3.5    Calcium Channel Blockers
        4.3.6    Analgesics
        4.3.7    Others
    4.4    Global Scleroderma Therapeutics Market Breakup by Indication
        4.4.1    Systemic
        4.4.2    Localized
    4.5    Global Scleroderma Therapeutics Market Breakup by Indication: Historical Market (2015-2019) & Forecast (2020-2025)
        4.5.1    Systemic
        4.5.2    Localized
    4.6    Global Scleroderma Therapeutics Market Breakup by Region
        4.6.1    North America
            4.6.1.1    United States of America
            4.6.1.2    Canada
        4.6.2    Europe
            4.6.2.1    Germany
            4.6.2.2    United Kingdom
            4.6.2.3    France
            4.6.2.4    Italy
            4.6.2.5    Others
        4.6.3    Asia Pacific
            4.6.3.1    China
            4.6.3.2    Japan
            4.6.3.3    India
            4.6.3.4    ASEAN
            4.6.3.5    Others
        4.6.4    Latin America
            4.6.4.1    Brazil
            4.6.4.2    Argentina
            4.6.4.3    Mexico
            4.6.4.4    Others
        4.6.5    Middle East & Africa
            4.6.5.1    Saudi Arabia
            4.6.5.2    United Arab Emirates
            4.6.5.3    Nigeria
            4.6.5.4    South Africa
            4.6.5.5    Others
    4.7     Global Scleroderma Therapeutics Market Breakup by Region: Historical Market (2015-2019) & Forecast (2020-2025)
        4.7.1    North America
            4.7.1.1    United States of America
            4.7.1.2    Canada
        4.7.2    Europe
            4.7.2.1    Germany
            4.7.2.2    United Kingdom
            4.7.2.3    France
            4.7.2.4    Italy
            4.7.2.5    Others
        4.7.3    Asia Pacific
            4.7.3.1    China
            4.7.3.2    Japan
            4.7.3.3    India
            4.7.3.4    ASEAN
            4.7.3.5    Others
        4.7.4    Latin America
            4.7.4.1    Brazil
            4.7.4.2    Argentina
            4.7.4.3    Mexico
            4.7.4.4    Others
        4.7.5    Middle East & Africa
            4.7.5.1    Saudi Arabia
            4.7.5.2    United Arab Emirates
            4.7.5.3    Nigeria
            4.7.5.4    South Africa
            4.7.5.5    Others
5    SWOT Analysis
    5.1    Overview
    5.2    Strengths
    5.3    Weaknesses
    5.4    Opportunities
    5.5    Threats
6    Porter’s Five Forces Analysis
    6.1    Overview
    6.2    Buyer’s Power
    6.3    Supplier’s Power
    6.4    New Entrants
    6.5    Degree of Rivalry
    6.6    Substitutes
7    Value Chain Analysis
8    EMR’s Key Indicators for Demand
9    EMR’s Key Indicators for Price
10    Competitive Landscape & Supplier Analysis

    10.1    F. Hoffman La Roche Ltd.
        10.1.1    Company Overview
        10.1.2    Financial Analysis
    10.2    Boehringer Ingelheim International GmbH
        10.2.1    Company Overview
        10.2.2    Financial Analysis
    10.3    Bristol-Myers Squibb Company [BMY (NYSE)]
        10.3.1    Company Overview
        10.3.2    Financial Analysis
    10.4    arGentis Pharmaceuticals, Llc
        10.4.1    Company Overview
        10.4.2    Financial Analysis
    10.5    Prometic Life Sciences Inc. [LMNL (TSE)]
        10.5.1    Company Overview
        10.5.2    Financial Analysis
    10.6    Akashi Therapeutics
        10.6.1    Company Overview
        10.6.2    Financial Analysis
    10.7    Kadmon Holdings, Inc.
        10.7.1    Company Overview
        10.7.2    Financial Analysis
    10.8    Emerald Health Pharmaceuticals. 
        10.8.1    Company Overview
        10.8.2    Financial Analysis
    10.9    Others
11    Events and Developments

Introduction

EMR is one of the foremost business intelligence and market research companies with a database of syndicated and customised reports spanning more than 100 industries across global and regional markets. We leverage the knowledge of our highly skilled team of over 100 analysts and more than 3000 independent consultants to provide our clients with thoroughly researched and reliable data tailored to their requirements. We help our clients, who range from Fortune 1000 companies to medium and niche enterprises, make informed strategic decisions through our varied tools and methodology.

Our meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. We understand the distinct nature and requirements for each industry and thus, modify our methodology to best fit the industry in question. Our research methodology uses a combination of cutting-edge analytical tools and the expertise of our highly accomplished team, thus, providing our customers with industry insights that are accurate, actionable, and help them remain ahead of their competition. EMR’ s fine-tuned research methodology and data analysis, formulated through years of cross-industry experience of our team, ensure that our clients are provided with:

  • Value-added and infallible market intelligence.
  • A holistic understanding of the current and expected market fluctuations through meticulously collected data.
  • Verified information on the probable opportunities and risks in the present and forecasted markets.
  • Validated and thoroughly analysed insights derived from our latest analytical tools and impeccable sources.

Assessment Approach

Our approach gives our clients a comprehensive assessment of the prevailing and projected industry conditions through the collection, collation, and analysis of data from trusted sources.

Price Assessment

We assess the historical, prevailing, and expected prices of commodities and raw materials by analysing our assiduously collected data from verified primary and secondary sources. Our assessments reflect the market values of related commodities within a region to help our consumers understand the interdependencies and formulate profitable industry strategies. Our price assessments cover both the average global prices along with the prevailing regional prices.

Market Assessment

Our market assessments determine the global and regional production and consumption of the product, according to their value and volume. We identify the key growth drivers, opportunities, and restraints that might promote or hinder the future industry growth along with an expansive overview of the competitive landscape to help our clients make informed strategic decisions. We also take into account the demographic, economic, cultural, and political factors that might influence the market.

Data Collection

We gather market intelligence through our extensive database of reliable secondary sources and our exhaustive interviews with multiple industry stakeholders. The information gathered through our primary and secondary sources help us verify and extrapolate data relating to prices, trade, and market fluctuations along with the latest developments in the industry.

Primary Research

As a part of our primary research, we interact with highly placed industrial professionals possessing an expansive and meticulous insight into the market. We conduct our interviews via mails, telephonic conversations, and one-on-one meetings. Thus, our exhaustive interviews with both buyers and consumers help us provide our clients with verified intelligence regarding the market size, share, drivers, prices, and forecast along with a detailed assessment of your supply chain.

Secondary Research

EMR has access to extensive internal and subscribed databases, which apprise us of the historical and prevailing industry conditions and help us forecast the market for the coming few years. Our secondary research involves a wide array of sources ranging from the annual and financial reports of the key players in the industry to governmental and regulatory databases. We refer to various scientific and industry publications and whitepapers to form a comprehensive understanding of the product and the supply chain. Our wide-ranging research also refers to relevant articles and press releases to provide our customers with an up-to-date understanding of the contemporary market. We derive extensive raw data from our secondary research, which then go through a thorough verification and validation process, to help us formulate an exhaustive understanding of the industry, the supply chain, the competitive landscape, and the product.

Other Analyst Tools and Data Models

Our extensive and intricate data models, formulated through our propriety technological and analytical resources, help you easily comprehend the expansive market data and aid you in framing vital business and industry strategies. Our tools provide you with a cohesive understanding of the industry outlook, taking into account the qualitative and quantitative market variables. Our analytical tools and models are regularly updated according to the changes in the continually evolving market scenarios as well as being adapted to best meet our client’s specific needs. Our research methods involve a blend of the best technological tools used in the industry along with the expertise of our analysts and consultants who can spot and assess the implications of the subtle factors influencing the more complex markets.

Data Prioritisation

Our market assessments take into consideration only those data that are confirmed and are derived from credible and transparent sources. Thus, our clients are presented with accurate and infallible data which can be incorporated into their business strategies.

Data Validation

Before our data is presented to the clients, they undergo an intensive cross-verification and validation process. We corroborate the data gathered through our primary and secondary research by the review and validation of the initial sources along with the verification of the data from other thoroughly vetted sources.

Exigent Data Assessment

Our qualitative and quantitative assessments are time-sensitive, reflecting the most recent value and volume of the market across regions. By constantly updating our databases and reports to reflect the changes taking place in the industry, our market and price assessments accurately reflect the prevailing industry conditions.

Thus, our rigorous data collection, thorough statistical analysis, and specialist assessments ensure that our clientele has a greater understanding of the industry space, supply chain, price fluctuations, competitive landscape, and other vital factors, helping them emerge as the undisputed industry leaders in their respective fields.

Purchase Options  

Buy Now  

Call us on

( USA & Canada )
+1-415-325-5166
us.sales@expertmarket
research.com
( United Kingdom )
+44-702-402-5790
uk.sales@expertmarket
research.com
Send Enquiry  

Purchase Full Report

  • Single User License
  • $2999
  • Restricted to one user
  • One print only
  • Available in PDF
  • Free limited customisation (pre sales)
  • Post sales analyst support
  • Free report update (Within 180 Days)
  • Buy Now
  • Five User License
  • $3999
  • Restricted to five users
  • One print per user
  • Available in PDF
  • Free limited customisation (pre sales)
  • Post sales analyst support
  • Free report update (Within 180 Days)
  • Buy Now
  • Corporate License
  • $4999
  • Unlimited users within organisation
  • No limit on prints
  • Available in PPT and PDF
  • Free limited customisation (pre sales)
  • Post sales analyst support
  • Free report update (Within 180 Days)
  • Buy Now

Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

Similar Reports

Expert Market Research Thumbnail Image
Global Thoracic Surgery Market Report and Forecast 2020-2025

A thoracic surgery involves any chest organ treatment or operation including the heart, lungs, oesophagus, as well as trachea. Thoracic surgery is also recognised as chest surgery. Thoracic surgery is...

  • 24 Hour Email Delivery
  • Price: $ 2999
Expert Market Research Thumbnail Image
Global Stretch Marks Treatment Market Report and Forecast 2020-2025

The global stretch marks treatment market is driven by the growing incidences of stretch marks across the globe. Further, the rising prevalence of obesity owing to the increasing fast food and changin...

  • 24 Hour Email Delivery
  • Price: $ 2999
Expert Market Research Thumbnail Image
Global Primary Biliary Cholangitis Therapeutics Market Report and Forecast 2020-2025

Primary biliary cholangitis refers to a rare chronic disease of the liver, formerly referred to as primary biliary cirrhosis, mainly characterized by the degradation of the biliary ducts, which contai...

  • 24 Hour Email Delivery
  • Price: $ 2999
Expert Market Research Thumbnail Image
Global Upper Respiratory Tract Infection Treatment Market Report and Forecast 2020-2025

An upper respiratory tract infection (URTI) is an illness, which is the result of an acute infection involving a person’s upper respiratory tract like the nose, sinuses, pharynx, or larynx. The infe...

  • 24 Hour Email Delivery
  • Price: $ 2999
Expert Market Research Thumbnail Image
Global Unicompartmental Knee Prostheses Market Report and Forecast 2020-2025

The global unicompartmental knee prostheses market is estimated to grow at a CAGR of almost 3.8% in the forecast period of 2020-2025. The global unicompartmental knee prostheses market is being driven...

  • 24 Hour Email Delivery
  • Price: $ 2999

Stay informed with our free industry updates.

Download Sample

Buy Full Version
"Scleroderma Therapeutics Market" Purchase Enquiry